xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05972005</url>
    </required_header>
    <id_info>
      <org_study_id>6032153</org_study_id>
      <nct_id>NCT05972005</nct_id>
    </id_info>
    <brief_title>Stronger at Home: Improving Outcomes for Older Adults After Hip Fracture</brief_title>
    <acronym>S@H</acronym>
    <official_title>Stronger at Home: Improve Functional Outcomes for Community-dwelling Older Adults After Hip Fracture</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Queen's University</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>Queen's University</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        The goal of this clinical trial is to compare the effectiveness of a new 14-week&#xD;
        individually-tailored home-based rehabilitation program called &quot;Stronger at Home&quot; with usual&#xD;
        care in improving functional recovery in community-dwelling older adults after hip fractures.&#xD;
  &#xD;
        The main question this trial aims to answer are:&#xD;
  &#xD;
        • Is the Stronger at Home program more effective than usual care in improving functional&#xD;
        recovery at the end of the 14-week intervention?&#xD;
  &#xD;
        secondary questions include:&#xD;
  &#xD;
          -  What is the cost-utility of the Stronger at Home program compared to usual care at 3.5&#xD;
             months, 6 months, and 12 months after discharge?&#xD;
  &#xD;
          -  Does the program have a sustained impact on functional recovery at 6 months and 12&#xD;
             months post-discharge?&#xD;
  &#xD;
        Participants in the trial will be asked to engage in the following tasks:&#xD;
  &#xD;
          -  Participate in the Stronger at Home program, which includes using a self-directed&#xD;
             toolkit consisting of educational resources and an illustrated exercise program.&#xD;
  &#xD;
          -  Follow the guidelines provided in the toolkit for gradually increasing exercise&#xD;
             intensity and incorporating different types of exercises into their daily life.&#xD;
  &#xD;
        The effects of the Stronger at Home program will be compared to those of usual care.&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        The primary research question of this project is whether the Stronger at Home program, a&#xD;
        14-week individually-tailored home-based rehabilitation program, is more effective than usual&#xD;
        care in improving functional recovery in community-dwelling older adults after hip fractures.&#xD;
        The evaluation of effectiveness will be conducted at the end of the intervention, which is&#xD;
        the primary time point.&#xD;
  &#xD;
        In addition to the main research question, secondary aims of the project include evaluating&#xD;
        the cost-utility of the Stronger at Home program compared to usual care at 3.5 months, 6&#xD;
        months, and 12 months after discharge. The program's impact on functional recovery will also&#xD;
        be assessed at medium-term (6 months) and long-term (12 months) follow-ups after the&#xD;
        participants are discharged from the hospital to their homes.&#xD;
  &#xD;
        The need for conducting this trial arises from a knowledge gap in effective rehabilitation&#xD;
        programs for community-dwelling individuals with hip fractures. The Stronger at Home program&#xD;
        was developed through a multistage study incorporating a self-directed toolkit and a new&#xD;
        model of care. The development process involved critical analysis of previous programs,&#xD;
        adherence to four principles of a successful program, and consultations with researchers,&#xD;
        policymakers, older adults, and clinicians. The toolkit includes an educational component and&#xD;
        an illustrated exercise program with progressively increasing intensity.&#xD;
  &#xD;
        The pilot study of the Stronger at Home program has shown feasibility, with positive feedback&#xD;
        from healthcare providers and patients regarding its value.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Not yet recruiting</overall_status>
    <start_date type="Anticipated">August 29, 2023</start_date>
    <completion_date type="Anticipated">July 29, 2028</completion_date>
    <primary_completion_date type="Anticipated">May 29, 2027</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>Randomized</allocation>
      <intervention_model>Parallel Assignment</intervention_model>
      <intervention_model_description>This randomized controlled trial (RCT) will be conducted over a period of 14 weeks, utilizing a parallel-group design. It will be a single-blind trial, meaning that the assessors will not be aware of participants assigned intervention. The trial will include repeated measures, with follow-ups conducted up to 12 months after the participants are discharged from the hospital.&#xD;
  In terms of its design, this trial is considered to be rather pragmatic to very pragmatic, as indicated by a score of 37 out of 45 on the PRECISE-2 tool. The PRECISE-2 tool is used to assess the level of pragmatism in clinical trials, helping to identify trials that closely resemble real-world conditions and are applicable to everyday practice.</intervention_model_description>
      <primary_purpose>Treatment</primary_purpose>
      <masking>Single (Outcomes Assessor)</masking>
      <masking_description>In this type of trial, the researchers responsible for assessing the outcomes remain unaware of the treatment assignments. The purpose of single-blind masking is to minimize bias and ensure that the assessment of outcomes is not influenced by researchers' expectations or knowledge of the treatment.</masking_description>
    </study_design_info>
    <primary_outcome>
      <measure>The Lower Extremity Functional Scale (LEFS)</measure>
      <time_frame>3.5 months (post intervention )</time_frame>
      <description>The primary outcome of the study (functional abilities) will be assessed using the Lower Extremity Functional Scale (LEFS), a patient-reported outcome measure consisting of 20 items. The LEFS has been validated for various populations, including patients recovering from hip surgeries, and has shown excellent reliability, validity, and responsiveness. It provides a score ranging from 0 to 80 based on the responses to each item's options. The LEFS was chosen based on its ability to evaluate important functional activities for patients, and its use as a primary outcome in the pilot study helped determine the sample size for this trial.</description>
    </primary_outcome>
    <secondary_outcome>
      <measure>The Short Physical Performance Battery (SPPB)</measure>
      <time_frame>Baseline, and at 3.5 months, 6 months, and 12 months after discharge.</time_frame>
      <description>The Short Physical Performance Battery (SPPB) will be used as a secondary measure of physical function. The SPPB is a performance-based assessment that includes three tests: standing balance, gait speed, and chair-rising. The total score ranges from 0 to 12, with higher scores indicating better lower extremity physical performance. The SPPB has been extensively validated and used in geriatric research.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Modified Falls Efficacy Scale</measure>
      <time_frame>Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.</time_frame>
      <description>The Modified Falls Efficacy Scale (MFES) is a commonly used self-report measure designed to assess an individual's confidence in their ability to perform daily activities without falling. It evaluates balance confidence and fear of falling in older adults or individuals with balance impairments. The scale consists of various activities or situations in which falls may occur, and respondents rate their level of confidence in performing each task without falling.&#xD;
  The MFES typically consists of 14 or 16 items, and each item is rated on a scale ranging from 0% (no confidence) to 100% (complete confidence). The items cover a wide range of activities, including both basic and more complex tasks such as walking on various surfaces, climbing stairs, reaching overhead, and getting out of a chair.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Pain measured with Numerical Analogue Scale (NAS)</measure>
      <time_frame>Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.</time_frame>
      <description>The NAS will be utilized to assess pain intensity. Participants will be asked to rate their pain levels at rest and during walking on a scale ranging from 0 to 10, with higher scores indicating greater pain intensity.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Tampa Scale of Kinesiophobia (TSK)</measure>
      <time_frame>Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.</time_frame>
      <description>The TSK will be employed to measure pain-related fear. It assesses individuals' fear and avoidance of physical activity due to pain and provides insights into how fear influences their functional recovery.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>2-Minute Walk Test (2MWT)</measure>
      <time_frame>Baseline, and at 3.5 months, 6 months, and 12 months after discharge.</time_frame>
      <description>The 2MWT will be conducted to evaluate participants' mobility endurance. It measures the distance covered by participants during a 2-minute walk, providing information about their aerobic capacity and endurance.</description>
    </secondary_outcome>
    <other_outcome>
      <measure>Health-Related Quality of Life (HRQL)</measure>
      <time_frame>Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.</time_frame>
      <description>HRQL refers to the impact of a health condition or intervention on a person's well-being. In this study, HRQL will be measured using the EQ-5D. EQ-5D is a generic instrument assessing HRQL across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three levels (1 = no problems, 2 = some problems, 3 = severe problems).</description>
    </other_outcome>
    <other_outcome>
      <measure>Quality-Adjusted Life Years (QALYs)</measure>
      <time_frame>within 7 days of discharge, as well as within 3.5 months, 6 months, 9 months, and 12 months.</time_frame>
      <description>QALYs are a measure of the quantity and quality of life lived. They combine information on HRQL and life expectancy to provide a single summary measure of health outcomes. QALYs will be calculated by assigning utility weights to the HRQL scores obtained from participants and multiplying them by the time spent in that health state.The measurement scale for QALYs ranges from 0 to 1, where 0 represents death and 1 represents perfect health. QALYs are calculated by multiplying the utility weight assigned to a specific health state (obtained from HRQL measures) by the time spent in that state.</description>
    </other_outcome>
    <number_of_arms>2</number_of_arms>
    <enrollment type="Anticipated">200</enrollment>
    <condition>Hip Fractures</condition>
    <arm_group>
      <arm_group_label>Intervention (Stronger at Home model)</arm_group_label>
      <arm_group_type>Experimental</arm_group_type>
      <description>This study implements a 14-week home-based rehabilitation program for older adults after hip fractures. Participants will receive 8 home visits by a Physiotherapist (PT) and/or Physio assistant(PTA), focusing on individualized exercise programs and pain self-management. The intervention aims to improve functional recovery and includes PT-led assessments, exercise adjustments, and discharge assessments. PTAs support exercise delivery and education. The clinical team comprises PTs and PTAs, receiving training on exercise principles, pain education, and goal setting. The program emphasizes progressive strengthening, balance, and functional exercises, adhering to evidence-based principles. The intervention aims to enhance efficiency, reduce wait times, and promote adherence.</description>
    </arm_group>
    <arm_group>
      <arm_group_label>Control (usual care)</arm_group_label>
      <arm_group_type>Active Comparator</arm_group_type>
      <description>The control group will receive usual home care provided by the healthcare system, which could vary between cases. We'll document their received care during follow-ups as it is inconsistent and poorly recorded. Regular check-in calls by the study coordinator will remind them of assessments, reducing attrition.</description>
    </arm_group>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>The Intervention (Stronger at Home Intervention)</intervention_name>
      <description>The home-based intervention includes 8 visits by a PT and/or PTA. The PT conducts 3 visits for initial assessment, program design, coaching, and discharge assessments. The program targets personal goals and provides pain self-management support. The second PT visit at 6 weeks allows for reassessment and adjustments. The intervention ensures adherence through multiple sessions, tailored exercises, barrier-solving support, and motivational strategies. The PTA conducts solo visits every other week, assisting with exercises and education under PT supervision. This inclusion reduces wait times and improves efficiency. The clinical team consists of at least 2 PTs and 2 PTAs trained for 3 days. The exercise program adheres to evidence-based principles, involving a 30-minute session with warm-up, exercise, and cooldown. Participants are encouraged to exercise 5 times a week, focusing on strengthening, balance, and functionality. Feasible compliance rates were observed in the pilot study.</description>
      <arm_group_label>Intervention (Stronger at Home model)</arm_group_label>
      <other_name>The Stronger at Home Physical Therapy program</other_name>
    </intervention>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>Usual care (Control)</intervention_name>
      <description>The control group will receive usual home care provided by the healthcare system, which could vary between cases. We'll document their received care during follow-ups as it is inconsistent and poorly recorded. Regular check-in calls by the study coordinator will remind them of assessments, reducing attrition.</description>
      <arm_group_label>Control (usual care)</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  Hip fracture patients who are 65 years or older,&#xD;
  &#xD;
            -  Currently living in the community, and&#xD;
  &#xD;
            -  Either being discharged to their home or a retirement home.&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Those who have a terminal illness,&#xD;
  &#xD;
            -  Individuals with significant contra-indications preventing exercise, such as rapidly&#xD;
               progressing neurological diseases.&#xD;
  &#xD;
            -  We have also set a geographical limitation, excluding participants who live outside&#xD;
               the city and surrounding area.&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>65 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <verification_date>July 2023</verification_date>
    <study_first_submitted>July 13, 2023</study_first_submitted>
    <study_first_submitted_qc>July 24, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 2, 2023</study_first_posted>
    <last_update_submitted>July 24, 2023</last_update_submitted>
    <last_update_submitted_qc>July 24, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 2, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Principal Investigator</responsible_party_type>
      <investigator_affiliation>Queen's University</investigator_affiliation>
      <investigator_full_name>Dr. Mohammad Auais, PhD</investigator_full_name>
      <investigator_title>Associate Professor, School Of Rehabilitation Therapy</investigator_title>
    </responsible_party>
    <keyword>Hip Fracture</keyword>
    <keyword>Exercise program</keyword>
    <keyword>Recovery</keyword>
    <keyword>Physical therapy</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Fractures, Bone</mesh_term>
      <mesh_term>Hip Fractures</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>No</sharing_ipd>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05972005
  org study id: 6032153
  nct id: NCT05972005
  lead sponsor: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  The goal of this clinical trial is to compare the effectiveness of a new 14-week
        individually-tailored home-based rehabilitation program called "Stronger at Home" with usual
        care in improving functional recovery in community-dwelling older adults after hip fractures.
  
        The main question this trial aims to answer are:
  
        • Is the Stronger at Home program more effective than usual care in improving functional
        recovery at the end of the 14-week intervention?
  
        secondary questions include:
  
          -  What is the cost-utility of the Stronger at Home program compared to usual care at 3.5
             months, 6 months, and 12 months after discharge?
  
          -  Does the program have a sustained impact on functional recovery at 6 months and 12
             months post-discharge?
  
        Participants in the trial will be asked to engage in the following tasks:
  
          -  Participate in the Stronger at Home program, which includes using a self-directed
             toolkit consisting of educational resources and an illustrated exercise program.
  
          -  Follow the guidelines provided in the toolkit for gradually increasing exercise
             intensity and incorporating different types of exercises into their daily life.
  
        The effects of the Stronger at Home program will be compared to those of usual care.
  The primary research question of this project is whether the Stronger at Home program, a
        14-week individually-tailored home-based rehabilitation program, is more effective than usual
        care in improving functional recovery in community-dwelling older adults after hip fractures.
        The evaluation of effectiveness will be conducted at the end of the intervention, which is
        the primary time point.
  
        In addition to the main research question, secondary aims of the project include evaluating
        the cost-utility of the Stronger at Home program compared to usual care at 3.5 months, 6
        months, and 12 months after discharge. The program's impact on functional recovery will also
        be assessed at medium-term (6 months) and long-term (12 months) follow-ups after the
        participants are discharged from the hospital to their homes.
  
        The need for conducting this trial arises from a knowledge gap in effective rehabilitation
        programs for community-dwelling individuals with hip fractures. The Stronger at Home program
        was developed through a multistage study incorporating a self-directed toolkit and a new
        model of care. The development process involved critical analysis of previous programs,
        adherence to four principles of a successful program, and consultations with researchers,
        policymakers, older adults, and clinicians. The toolkit includes an educational component and
        an illustrated exercise program with progressively increasing intensity.
  
        The pilot study of the Stronger at Home program has shown feasibility, with positive feedback
        from healthcare providers and patients regarding its value.
  allocation: Randomized
  intervention model: Parallel Assignment
  intervention model description: This randomized controlled trial (RCT) will be conducted over a period of 14 weeks, utilizing a parallel-group design. It will be a single-blind trial, meaning that the assessors will not be aware of participants assigned intervention. The trial will include repeated measures, with follow-ups conducted up to 12 months after the participants are discharged from the hospital.
  In terms of its design, this trial is considered to be rather pragmatic to very pragmatic, as indicated by a score of 37 out of 45 on the PRECISE-2 tool. The PRECISE-2 tool is used to assess the level of pragmatism in clinical trials, helping to identify trials that closely resemble real-world conditions and are applicable to everyday practice.
  primary purpose: Treatment
  masking: Single (Outcomes Assessor)
  masking description: In this type of trial, the researchers responsible for assessing the outcomes remain unaware of the treatment assignments. The purpose of single-blind masking is to minimize bias and ensure that the assessment of outcomes is not influenced by researchers' expectations or knowledge of the treatment.
  measure: The Lower Extremity Functional Scale (LEFS)
  time frame: 3.5 months (post intervention )
  description: The primary outcome of the study (functional abilities) will be assessed using the Lower Extremity Functional Scale (LEFS), a patient-reported outcome measure consisting of 20 items. The LEFS has been validated for various populations, including patients recovering from hip surgeries, and has shown excellent reliability, validity, and responsiveness. It provides a score ranging from 0 to 80 based on the responses to each item's options. The LEFS was chosen based on its ability to evaluate important functional activities for patients, and its use as a primary outcome in the pilot study helped determine the sample size for this trial.
  measure: The Short Physical Performance Battery (SPPB)
  time frame: Baseline, and at 3.5 months, 6 months, and 12 months after discharge.
  description: The Short Physical Performance Battery (SPPB) will be used as a secondary measure of physical function. The SPPB is a performance-based assessment that includes three tests: standing balance, gait speed, and chair-rising. The total score ranges from 0 to 12, with higher scores indicating better lower extremity physical performance. The SPPB has been extensively validated and used in geriatric research.
  measure: Modified Falls Efficacy Scale
  time frame: Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.
  description: The Modified Falls Efficacy Scale (MFES) is a commonly used self-report measure designed to assess an individual's confidence in their ability to perform daily activities without falling. It evaluates balance confidence and fear of falling in older adults or individuals with balance impairments. The scale consists of various activities or situations in which falls may occur, and respondents rate their level of confidence in performing each task without falling.
  The MFES typically consists of 14 or 16 items, and each item is rated on a scale ranging from 0% (no confidence) to 100% (complete confidence). The items cover a wide range of activities, including both basic and more complex tasks such as walking on various surfaces, climbing stairs, reaching overhead, and getting out of a chair.
  measure: Pain measured with Numerical Analogue Scale (NAS)
  time frame: Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.
  description: The NAS will be utilized to assess pain intensity. Participants will be asked to rate their pain levels at rest and during walking on a scale ranging from 0 to 10, with higher scores indicating greater pain intensity.
  measure: Tampa Scale of Kinesiophobia (TSK)
  time frame: Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.
  description: The TSK will be employed to measure pain-related fear. It assesses individuals' fear and avoidance of physical activity due to pain and provides insights into how fear influences their functional recovery.
  measure: 2-Minute Walk Test (2MWT)
  time frame: Baseline, and at 3.5 months, 6 months, and 12 months after discharge.
  description: The 2MWT will be conducted to evaluate participants' mobility endurance. It measures the distance covered by participants during a 2-minute walk, providing information about their aerobic capacity and endurance.
  measure: Health-Related Quality of Life (HRQL)
  time frame: Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.
  description: HRQL refers to the impact of a health condition or intervention on a person's well-being. In this study, HRQL will be measured using the EQ-5D. EQ-5D is a generic instrument assessing HRQL across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three levels (1 = no problems, 2 = some problems, 3 = severe problems).
  measure: Quality-Adjusted Life Years (QALYs)
  time frame: within 7 days of discharge, as well as within 3.5 months, 6 months, 9 months, and 12 months.
  description: QALYs are a measure of the quantity and quality of life lived. They combine information on HRQL and life expectancy to provide a single summary measure of health outcomes. QALYs will be calculated by assigning utility weights to the HRQL scores obtained from participants and multiplying them by the time spent in that health state.The measurement scale for QALYs ranges from 0 to 1, where 0 represents death and 1 represents perfect health. QALYs are calculated by multiplying the utility weight assigned to a specific health state (obtained from HRQL measures) by the time spent in that state.
  arm group label: Intervention (Stronger at Home model)
  arm group type: Experimental
  description: This study implements a 14-week home-based rehabilitation program for older adults after hip fractures. Participants will receive 8 home visits by a Physiotherapist (PT) and/or Physio assistant(PTA), focusing on individualized exercise programs and pain self-management. The intervention aims to improve functional recovery and includes PT-led assessments, exercise adjustments, and discharge assessments. PTAs support exercise delivery and education. The clinical team comprises PTs and PTAs, receiving training on exercise principles, pain education, and goal setting. The program emphasizes progressive strengthening, balance, and functional exercises, adhering to evidence-based principles. The intervention aims to enhance efficiency, reduce wait times, and promote adherence.
  arm group label: Control (usual care)
  arm group type: Active Comparator
  description: The control group will receive usual home care provided by the healthcare system, which could vary between cases. We'll document their received care during follow-ups as it is inconsistent and poorly recorded. Regular check-in calls by the study coordinator will remind them of assessments, reducing attrition.
  intervention type: Other
  intervention name: The Intervention (Stronger at Home Intervention)
  description: The home-based intervention includes 8 visits by a PT and/or PTA. The PT conducts 3 visits for initial assessment, program design, coaching, and discharge assessments. The program targets personal goals and provides pain self-management support. The second PT visit at 6 weeks allows for reassessment and adjustments. The intervention ensures adherence through multiple sessions, tailored exercises, barrier-solving support, and motivational strategies. The PTA conducts solo visits every other week, assisting with exercises and education under PT supervision. This inclusion reduces wait times and improves efficiency. The clinical team consists of at least 2 PTs and 2 PTAs trained for 3 days. The exercise program adheres to evidence-based principles, involving a 30-minute session with warm-up, exercise, and cooldown. Participants are encouraged to exercise 5 times a week, focusing on strengthening, balance, and functionality. Feasible compliance rates were observed in the pilot study.
  arm group label: Intervention (Stronger at Home model)
  other name: The Stronger at Home Physical Therapy program
  intervention type: Other
  intervention name: Usual care (Control)
  description: The control group will receive usual home care provided by the healthcare system, which could vary between cases. We'll document their received care during follow-ups as it is inconsistent and poorly recorded. Regular check-in calls by the study coordinator will remind them of assessments, reducing attrition.
  arm group label: Control (usual care)
  criteria: 
  gender: All
  minimum age: 65 Years
  maximum age: N/A
  healthy volunteers: No
  responsible party type: Principal Investigator
  investigator affiliation: Queen's University
  investigator full name: Dr. Mohammad Auais, PhD
  investigator title: Associate Professor, School Of Rehabilitation Therapy
  mesh term: Fractures, Bone
  mesh term: Hip Fractures
  sharing ipd: No